Hostname: page-component-78c5997874-v9fdk Total loading time: 0 Render date: 2024-11-18T06:20:44.230Z Has data issue: false hasContentIssue false
  • English
  • Français

Influence of gestational age on serum incretin levels in preterm infants

Published online by Cambridge University Press:  25 July 2016

H. Shoji ,
A. Watanabe ,
N. Ikeda ,
M. Mori ,
T. Kitamura ,
K. Hisata  and
T. Shimizu
H. Shoji*
Affiliation:
Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
A. Watanabe
Affiliation:
Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
N. Ikeda
Affiliation:
Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
M. Mori
Affiliation:
Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
T. Kitamura
Affiliation:
Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
K. Hisata
Affiliation:
Department of Pediatrics, Juntendo University Faculty of Medicine, Tokyo, Japan
T. Shimizu
Affiliation:
Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, Tokyo, Japan
*
*Address for correspondence: H. Shoji, Department of Pediatrics and Adolescent Medicine, Juntendo University Graduate School of Medicine, 2-1-1 Hongo, Bunkyo-ku, Tokyo 113-8421, Japan. (Email [email protected])
Get access Rights & Permissions [Opens in a new window]

Abstract

Glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) are the incretin hormones secreted from the intestine in response to enteral feeding to stimulate insulin secretion. We investigated the relationship serum GIP and GLP-1 levels with gestational age, and insulin secretion in preterm infants. Serum GIP and GLP-1 levels were measured at birth and at 1, 2 and 4 weeks after birth in 30 infants, including 12 born before 30th week of gestation (early group) and 18 born after 30th week of gestation (late group). Blood glucose and serum insulin levels were measured, and the quantitative insulin sensitivity check index (QUICKI) was also calculated. The levels of GLP-1 at 2 and 4 weeks were significantly higher in the early group than those in the late group. The levels of GIP were not significantly different between two groups. At 4 weeks, serum insulin level was significantly higher and QUICKI was significantly lower in the early group. Furthermore, GLP-1 levels were significantly correlated with QUICKI and the serum insulin levels in all infants at 4 weeks. In preterm infants, enteral feeding to premature intestine may be associated with GLP-1 secretion. GLP-1 is also related to stimulated insulin secretion in early postnatal period.

Keywords

glucagon-like peptide-1glucose-dependent insulinotropic polypeptideinsulinincretinpreterm infants
Type
Original Article
Information
Journal of Developmental Origins of Health and Disease , Volume 7 , Issue 6: Themed Issue: Developmental Origins of Adult Mental Health and Illness , December 2016 , pp. 685 - 688
Check for updates
Copyright
© Cambridge University Press and the International Society for Developmental Origins of Health and Disease 2016 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Itabashi, K, Horiuchi, T, Kusuda, S, et al. Mortality rates for extremely low birth weight infants born in Japan in 2005. Pediatrics. 2009; 123, 445–450.CrossRefGoogle ScholarPubMed
2. Singhal, A, Farooqi, IS, O’Rahilly, S, et al. Early nutrition and leptin concentrations in later life. Am J Clin Nutr. 2002; 75, 993–999.CrossRefGoogle ScholarPubMed
3. Singhal, A, Fewtrell, M, Cole, TJ, Lucas, A. Low nutrient intake and early growth for later insulin resistance in adolescents born preterm. Lancet. 2003; 361, 1089–1097.CrossRefGoogle ScholarPubMed
4. Ten, S, Maclaren, N. Insulin resistance syndrome in children. J Clin Endocrinol Metab. 2004; 89, 2526–2539.Google Scholar
5. Baggio, LL, Drucker, DJ. Biology of incretins: GLP-1 and GIP. Gastroenterology. 2007; 132, 2131–2157.CrossRefGoogle ScholarPubMed
6. Ambati, S, Duan, J, Hartzell, DL, et al. GIP-dependent expression of hypothalamic genes. Physiol Res. 2011; 60, 941–950.Google Scholar
7. Kawamata, R, Suzuki, Y, Yada, Y, et al. Gut hormones of preterm infants with abdominal symptoms and hypothyroxinemia. Pediatr Int. 2015; 57, 614–619.CrossRefGoogle ScholarPubMed
8. Kawamata, R, Suzuki, Y, Yada, Y, et al. Gut hormone profiles in preterm and term infants during the first 2 months of life. J Pediatr Endocrinol Metab. 2014; 27, 717–723.Google Scholar
9. Itabashi, K, Miura, F, Uehara, R, Nakamura, Y. New Japanese neonatal anthropometric charts for gestational age at birth. Pediatr Int. 2014; 56, 702–708.Google Scholar
10. Padidela, R, Patterson, M, Sharief, N, Ghatei, M, Hussain, K. Elevated basal and post-feed glucagon-like peptide 1 (GLP-1) concentrations in the neonatal period. Eur J Endocrinol. 2009; 160, 53–58.Google Scholar
11. Berseth, CL, Nordyke, CK, Valdes, MG, Furlow, BL, Go, VL. Responses of gastrointestinal peptides and motor activity to milk and water feedings in preterm and term infants. Pediatr Res. 1992; 31, 587–590.Google Scholar
12. Detel, D, Baticic, L, Varljen, J. The influence of age on intestinal dipeptidyl peptidase IV (DPP IV/CD26), disaccharidases, and alkaline phosphatase enzyme activity in C57BL/6 mice. Exp Aging Res. 2008; 34, 49–62.CrossRefGoogle ScholarPubMed
13. Hvidberg, A, Nielsen, MT, Hilsted, J, Orskov, C, Holst, JJ. Effect of glucagon-like peptide-1 (proglucagon 78-107amide) on hepatic glucose production in healthy man. Metabolism. 1994; 43, 104–108.Google Scholar
14. Buteau, J, Foisy, S, Rhodes, CJ, et al. Protein kinase Czeta activation mediates glucagon-like peptide-1-induced pancreatic beta-cell proliferation. Diabetes. 2001; 50, 2237–2243.CrossRefGoogle ScholarPubMed
15. Buteau, J, Foisy, S, Joly, E, Prentki, M. Glucagon-like peptide 1 induces pancreatic beta-cell proliferation via transactivation of the epidermal growth factor receptor. Diabetes. 2003; 52, 124–132.CrossRefGoogle ScholarPubMed
16. Farilla, L, Hui, H, Bertolotto, C, et al. Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats. Endocrinology. 2002; 143, 4397–4408.Google Scholar
17. Flint, A, Raben, A, Astrup, A, Holst, JJ. Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans. J Clin Invest. 1998; 101, 515–520.Google Scholar
18. Small, CJ, Bloom, SR. Gut hormones and the control of appetite. Trends Endocrinol Metab. 2004; 15, 259–263.Google Scholar
19. Lucas, A, Boyes, S, Bloom, SR, Aynsley-Green, A. Metabolic and endocrine responses to a milk feed in six-day-old term infants: differences between breast and cow’s milk formula feeding. Acta Paediatr Scand. 1981; 70, 195–200.Google Scholar
20. Wang, G, Divall, S, Radovick, S, et al. Preterm birth and random plasma insulin levels at birth and in early childhood. JAMA. 2014; 311, 587–596.CrossRefGoogle ScholarPubMed